Discontinued — last reported Q2 '19
An increase indicates growing demand for the company's proprietary technology within the partner's ecosystem or expanded scope of the collaboration, while a decrease may signal reduced partner utilization or contract renegotiations.
This metric represents the gross revenue generated specifically from the partnership or service agreement with Qiagen, e...
Similar to revenue from strategic licensing agreements or OEM partnerships found in other life sciences and diagnostic companies, where revenue is tied to specific third-party distribution or technology integration.
ntra_segment_qiagen_revenue_from_contract_with_customer_excluding_assessed_tax